Regulatory Considerations for Early Clinical Development of Drugs for Diabetes, Obesity, and Cardiometabolic Disorders
Fig. 12.1 The major components of the Common Technical Document (CTD) Recent History in the FDA Review Divisions More recent history of the FDA reviews involved in cardiometabolic therapeutic regulation…